Ultralife Co. (NASDAQ:ULBI) Shares Purchased by Barclays PLC

Barclays PLC increased its holdings in shares of Ultralife Co. (NASDAQ:ULBI) by 21.3% during the third quarter, HoldingsChannel.com reports. The fund owned 13,395 shares of the technology company’s stock after buying an additional 2,355 shares during the period. Barclays PLC’s holdings in Ultralife were worth $121,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. ClariVest Asset Management LLC boosted its holdings in Ultralife by 2.9% in the 2nd quarter. ClariVest Asset Management LLC now owns 66,657 shares of the technology company’s stock valued at $708,000 after purchasing an additional 1,864 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in Ultralife by 4.4% in the 2nd quarter. Acadian Asset Management LLC now owns 146,635 shares of the technology company’s stock valued at $1,556,000 after purchasing an additional 6,206 shares during the last quarter. Janney Montgomery Scott LLC boosted its holdings in Ultralife by 2.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 443,150 shares of the technology company’s stock valued at $4,006,000 after purchasing an additional 10,450 shares during the last quarter. Rhumbline Advisers boosted its holdings in Ultralife by 1,728.3% in the 2nd quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock valued at $125,000 after purchasing an additional 11,165 shares during the last quarter. Finally, Juncture Wealth Strategies LLC acquired a new position in Ultralife in the 3rd quarter valued at about $165,000. 30.68% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Benchmark reiterated a “buy” rating and issued a $14.00 target price on shares of Ultralife in a report on Friday, November 15th. StockNews.com lowered shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

Ultralife Price Performance

Shares of ULBI opened at $7.39 on Thursday. Ultralife Co. has a fifty-two week low of $6.63 and a fifty-two week high of $13.39. The firm’s 50 day moving average price is $7.74 and its 200 day moving average price is $9.22. The company has a market cap of $122.87 million, a P/E ratio of 13.44 and a beta of 0.96. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04.

Ultralife Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.